Retinal toxicity of intravitreal tissue plasminogen activator: Case report and literature review

Ophthalmology

Volumn 110, Issue 4, 2003, Pages 704-708

  Chen, San Ni ^a,c   Yang, Te Cheng ^b   Ho, Cheng Lien ^a   Kuo, Ya Hui ^a   Yip, Yeung ^a   Chao, An Ning ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

A WAVE; ACUTE HEART INFARCTION; ADULT; ARTICLE; B WAVE; CASE REPORT; DRUG EFFECT; ELECTRORETINOGRAPHY; EYE TOXICITY; HUMAN; IRIDECTOMY; MALE; NIGHT VISION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA HEMORRHAGE; VISUAL ACUITY; VITRECTOMY;

EID: 0242500326     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01979-6     Document Type: Article

References (12)

1. Jaffe GJ, Abrams GW, Williams GA, Han DP. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology 1990;97:184-9.
2. MacCumber MW, McCuen BW II, Toth CA, et al. Tissue plasminogen activator for preserving inferior peripheral iridectomy patency in eyes with silicone oil. Ophthalmology 1996;103:269-73.
3. Johnson MW, Oslen KR, Hernandez E. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage. Ophthalmology 1992;99:515-21.
4. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
5. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-7.
6. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-6; discussion 1906-7.
7. Johnson RN, Olsen KR, Hernandez E. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage. Arch Ophthalmol 1989;107:891-4.
8. Hrach CJ, Johnson MW, Hassan AS, et al. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 2000;118:659-63.
9. Johnson MW, Oslen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-63.
10. Irvine WD, Johnson MW, Hernandez E, Oslen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 1991;109:718-22.
11. Handwerger BA, Blodi BA, Chandra SR, et al. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 2001;119:28-32.
12. Ohji M, Saito Y, Hayashi A, et al. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-32.